Rep. Kennedy Signs Letter Urging Investigation into Foreign Drug Pricing Practices Shifting Costs to Americans
their fair share for American pharmaceutical innovation. Many countries benefit from the U.S.-developed medicines while implementing policies … patients.” Background: Despite warnings from the Administration, some countries, including Germany and Switzerland, have recently announced plans